Contraception
RSSArticles
-
New Congressional Funding for STD Programs: Is It Enough?
Congress recently increased federal funding for sexually transmitted disease (STD) prevention for the first time since 2003, with a $3.51 million addition in base funding to the CDC’s STD prevention programs. But is the funding enough to fully address the rise in national STD rates?
-
Consensus Position Statement on the Use of Testosterone in Women
Clinicians lack clearly established guidance and indications for testosterone therapy for women, which has led to considerable variation in practice patterns. The absence of clear indications and approved products for women has resulted in the use of compounded therapies or off-label prescription of testosterone formulations approved for men.
-
Check Your Practice: Are Unnecessary Pelvic Exams and Pap Tests Being Performed?
While pelvic examinations and cervical cancer screenings are no longer recommended for most young women under age 21 years during routine health visits, results from a new national study indicate that millions of women are undergoing these tests unnecessarily.
-
Research Examines Effect of Pregnancy Preferences on Contraceptive Use
Researchers found that women with a strong preference to avoid pregnancy were far more likely to use any contraceptive method. However, more than 50% of women who reported a low preference to avoid pregnancy used some form of birth control.
-
Postpartum LARC: Highly Effective, but Restricted by Some Hospitals
Women who receive care in Catholic facilities may be denied postpartum LARC due to religious directives that ban such care. In 10 states, more than 30% of all hospital beds are in Catholic facilities. In about 50% of states, more than one in five hospital beds is in a Catholic facility.
-
Help Women Take Charge of Breast Cancer Risks
About one in three breast cancer cases could be prevented by lifestyle modifications such as weight management, exercise, diet, and alcohol consumption, according to a recent presentation at the North American Menopause Society 2019 Annual Meeting.
-
Progesterone After Mifepristone to Halt Medication Abortion: Is It Safe?
Results of a new study indicated that women who initiate medication abortion but opt to stop in the middle of treatment may be at risk for serious blood loss.
-
Researchers Examine Use of Dichloroacetate in Endometriosis Treatment
The authors of a new scientific paper indicate that dichloroacetate, investigated as a potential cancer treatment, may be effective against endometriosis. Finding a new treatment option would augment current treatment strategies of hormone therapy and surgery, which involve significant side effects and recurrence after treatment.
-
Research Focuses on Medroxyprogesterone Acetate in Cervical Cancer Prevention
Preliminary research suggests that medroxyprogesterone acetate, the active ingredient in the contraceptive injection DMPA, may be effective in preventing cervical cancer.
-
Policy Update Advocates Teen Access to Emergency Contraception
To help prevent unplanned pregnancy among adolescents, the American Academy of Pediatrics has issued an updated policy statement on emergency contraception (EC) to educate providers on use of EC in adolescents, and advocate for expanded access for teens.